Ligand Pharmaceuticals (LGND)
(Delayed Data from NSDQ)
$102.80 USD
-2.21 (-2.10%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $102.78 -0.02 (-0.02%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMKey Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/13/2024
Time: -- |
9/2024 | $1.18 | 0.00% |
Earnings Summary
For their last quarter, Ligand Pharmaceuticals (LGND) reported earnings of $1.40 per share, beating the Zacks Consensus Estimate of $1.10 per share. This reflects a positive earnings surprise of 27.27%. Look out for LGND's next earnings release expected on November 13, 2024. For the next earning release, we expect the company to report earnings of $1.18 per share, reflecting a year-over-year increase of 15.69%.
Earnings History
Price & Consensus
Zacks News for LGND
Gilead (GILD) Up as Twice-Yearly HIV Shot Prevents Infection
LGND: What are Zacks experts saying now?
Zacks Private Portfolio Services